Copyright Reports & Markets. All rights reserved.

Global Human Reproductive Technologies Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Human Reproductive Technologies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 In Vitro Fertilization (IVF)
      • 1.4.3 Intracytoplasmic Sperm Injection (ICSI)
      • 1.4.4 Zygote Intrafallopian Transfer (ZIFT)
      • 1.4.5 Gamete Intrafallopian Transfer (GIFT)
      • 1.4.6 Intrauterine Insemination (IUI)
      • 1.4.7 Contraceptive Technology
    • 1.5 Market by Application
      • 1.5.1 Global Human Reproductive Technologies Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Fertility Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Human Reproductive Technologies Market Size
    • 2.2 Human Reproductive Technologies Growth Trends by Regions
      • 2.2.1 Human Reproductive Technologies Market Size by Regions (2014-2025)
      • 2.2.2 Human Reproductive Technologies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Human Reproductive Technologies Market Size by Manufacturers
      • 3.1.1 Global Human Reproductive Technologies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Human Reproductive Technologies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Human Reproductive Technologies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Reproductive Technologies Key Players Head office and Area Served
    • 3.3 Key Players Human Reproductive Technologies Product/Solution/Service
    • 3.4 Date of Enter into Human Reproductive Technologies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Human Reproductive Technologies Market Size by Type (2014-2019)
    • 4.2 Global Human Reproductive Technologies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Human Reproductive Technologies Market Size (2014-2019)
    • 5.2 Human Reproductive Technologies Key Players in United States
    • 5.3 United States Human Reproductive Technologies Market Size by Type
    • 5.4 United States Human Reproductive Technologies Market Size by Application

    6 Europe

    • 6.1 Europe Human Reproductive Technologies Market Size (2014-2019)
    • 6.2 Human Reproductive Technologies Key Players in Europe
    • 6.3 Europe Human Reproductive Technologies Market Size by Type
    • 6.4 Europe Human Reproductive Technologies Market Size by Application

    7 China

    • 7.1 China Human Reproductive Technologies Market Size (2014-2019)
    • 7.2 Human Reproductive Technologies Key Players in China
    • 7.3 China Human Reproductive Technologies Market Size by Type
    • 7.4 China Human Reproductive Technologies Market Size by Application

    8 Japan

    • 8.1 Japan Human Reproductive Technologies Market Size (2014-2019)
    • 8.2 Human Reproductive Technologies Key Players in Japan
    • 8.3 Japan Human Reproductive Technologies Market Size by Type
    • 8.4 Japan Human Reproductive Technologies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Human Reproductive Technologies Market Size (2014-2019)
    • 9.2 Human Reproductive Technologies Key Players in Southeast Asia
    • 9.3 Southeast Asia Human Reproductive Technologies Market Size by Type
    • 9.4 Southeast Asia Human Reproductive Technologies Market Size by Application

    10 India

    • 10.1 India Human Reproductive Technologies Market Size (2014-2019)
    • 10.2 Human Reproductive Technologies Key Players in India
    • 10.3 India Human Reproductive Technologies Market Size by Type
    • 10.4 India Human Reproductive Technologies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Human Reproductive Technologies Market Size (2014-2019)
    • 11.2 Human Reproductive Technologies Key Players in Central & South America
    • 11.3 Central & South America Human Reproductive Technologies Market Size by Type
    • 11.4 Central & South America Human Reproductive Technologies Market Size by Application

    12 International Players Profiles

    • 12.1 bbott Laboratories, Inc.
      • 12.1.1 bbott Laboratories, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Human Reproductive Technologies Introduction
      • 12.1.4 bbott Laboratories, Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.1.5 bbott Laboratories, Inc. Recent Development
    • 12.2 Actavis, Inc.
      • 12.2.1 Actavis, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Human Reproductive Technologies Introduction
      • 12.2.4 Actavis, Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.2.5 Actavis, Inc. Recent Development
    • 12.3 Bayer AG
      • 12.3.1 Bayer AG Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Human Reproductive Technologies Introduction
      • 12.3.4 Bayer AG Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.3.5 Bayer AG Recent Development
    • 12.4 Church & Dwight, Co. Inc.
      • 12.4.1 Church & Dwight, Co. Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Human Reproductive Technologies Introduction
      • 12.4.4 Church & Dwight, Co. Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.4.5 Church & Dwight, Co. Inc. Recent Development
    • 12.5 Cook Medical, Inc.
      • 12.5.1 Cook Medical, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Human Reproductive Technologies Introduction
      • 12.5.4 Cook Medical, Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.5.5 Cook Medical, Inc. Recent Development
    • 12.6 Ferring International Center S.A.
      • 12.6.1 Ferring International Center S.A. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Human Reproductive Technologies Introduction
      • 12.6.4 Ferring International Center S.A. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.6.5 Ferring International Center S.A. Recent Development
    • 12.7 Johnson & Johnson
      • 12.7.1 Johnson & Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Human Reproductive Technologies Introduction
      • 12.7.4 Johnson & Johnson Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.7.5 Johnson & Johnson Recent Development
    • 12.8 Merck & Co., Inc.
      • 12.8.1 Merck & Co., Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Human Reproductive Technologies Introduction
      • 12.8.4 Merck & Co., Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.8.5 Merck & Co., Inc. Recent Development
    • 12.9 Merck Serono
      • 12.9.1 Merck Serono Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Human Reproductive Technologies Introduction
      • 12.9.4 Merck Serono Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.9.5 Merck Serono Recent Development
    • 12.10 Pfizer, Inc.
      • 12.10.1 Pfizer, Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Human Reproductive Technologies Introduction
      • 12.10.4 Pfizer, Inc. Revenue in Human Reproductive Technologies Business (2014-2019)
      • 12.10.5 Pfizer, Inc. Recent Development
    • 12.11 Reckitt Benckiser Group plc
    • 12.12 Teva Pharmaceutical Industries Ltd.
    • 12.13 Warner Chilcott plc.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Human Reproductive Technologies (or Assisted reproductive technology (ART)) is used to treat infertility. It includes fertility treatments that handle both a woman's egg and a man's sperm. It works by removing eggs from a woman's body. The eggs are then mixed with sperm to make embryos. The embryos are then put back in the woman's body. In vitro fertilization (IVF) is the most common and effective type of ART.
      In 2018, the global Human Reproductive Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Human Reproductive Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Reproductive Technologies development in United States, Europe and China.

      The key players covered in this study
      bbott Laboratories, Inc.
      Actavis, Inc.
      Bayer AG
      Church & Dwight, Co. Inc.
      Cook Medical, Inc.
      Ferring International Center S.A.
      Johnson & Johnson
      Merck & Co., Inc.
      Merck Serono
      Pfizer, Inc.
      Reckitt Benckiser Group plc
      Teva Pharmaceutical Industries Ltd.
      Warner Chilcott plc.

      Market segment by Type, the product can be split into
      In Vitro Fertilization (IVF)
      Intracytoplasmic Sperm Injection (ICSI)
      Zygote Intrafallopian Transfer (ZIFT)
      Gamete Intrafallopian Transfer (GIFT)
      Intrauterine Insemination (IUI)
      Contraceptive Technology

      Market segment by Application, split into
      Hospitals
      Fertility Clinics

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Human Reproductive Technologies status, future forecast, growth opportunity, key market and key players.
      To present the Human Reproductive Technologies development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Human Reproductive Technologies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now